Metacrine, Inc.
USD0.58
-0.01 (-1.29%)
CEO
David M. Maggio
IPO Date
2020-09-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.59
Prev. Close
$0.59
Day Low
$0.58
Day High
$0.59
52W Low
$0.30
52W High
$0.59
Volume
0.08M
| -2.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 37.4% | -48.6% | -0.15 | 4.09 | -7.7 |
| 31 Dec 2018 | FY | 100.0% | -1780.8% | 50.2% | -33.2% | -0.06 | 17.44 | -8.7 |
| -0.8 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -28.5% | -19.9% | 0.29 | 12.19 | -0.5 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -24.4% | -17.5% | 0.25 | 10.15 | -0.5 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -38.9% | -27.1% | 0.23 | 6.33 | -1.2 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -24.6% | -19.1% | 0.17 | 10.63 | -1.6 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -19.3% | -15.9% | 0.14 | 17.33 | -2.8 |
| 31 Dec 2020 | Q4 | 0.0% | 0.0% | -12.1% | -10.4% | 0.21 | 25.34 | -4.7 |
| 30 Sept 2020 | Q3 | 0.0% | 0.0% | -9.2% | -8.0% | 0.11 | 27.04 | -0.4 |
| 30 Jun 2020 | Q2 | 0.0% | 0.0% | -32.6% | -20.9% | 0.40 | 2.83 | -8.2 |